Skip to main content


2018 Education Day


The 2018 Education Day will focus on the rapidly evolving advances in Clinical Trials and how these advances have affected the Neuro-Oncology community. Strategies in decision making for rational selection of targeted agents, biomarkers and anti-tumor therapies for clinical trials will be discussed, as well as the changing paradigms in clinical trial design and endpoints that should be measured. Challenges in improving accrual to clinical trials and identifying barriers to enrollment will also be explored, in addition to strategies that are being employed to improve access to clinical trials. This exciting program should prove to be of value and interest to all basic science, clinical, and allied health attendees.

To view a copy of the preliminary program, click here.

Education Day Chairs:
Brian Alexander, MD, MPH
Ingo Mellinghoff, MD
Joohee Sul, MD
Martin Taphoorn, MD, PhD